Kelley Skoloda

Chief Marketing & Communications Officer | Growth Advisor | Helping healthcare systems, associations, legacy businesses, and growth-stage companies navigate growth, relevance and transition

๐Ÿ“ Pittsburgh, Pennsylvania, United States๐Ÿ”„ Updated September 2026๐Ÿ’ผ 5 investments๐Ÿ“… 7 years investing๐Ÿ—“ Last invested Sep 2020๐• @upgrade_to_unlock
VC๐ŸŒ United States
5
Total investments
1
Early stage
2
Mid stage
0
Late stage
7y
Years active

Portfolio

3 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Mar 2020
A talent marketplace that uses innovative technology, career development, and a focus on skills-based hiring to create employment solutions for companies and remote careers for military and veteran spouses. Visit us at instantteams.com to learn more.
Private Investor
Oct 2019
Joylux is a leading menopausal platform company offering high-tech, home-use medical and wellness devices, digital tools, and products that address menopause-related intimate health concerns. Anchored by our innovative vFit Gold device โ€“ the first home-use device using the power of red light to improve vaginal wellness โ€“ and supported by the Joylux Gold app, our products are Ob-Gyn designed with one goal in mind: empowering women to feel healthy and confident in every stage of their lives.
Private Investor
Jun 2019
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. There are many causes of CRS and our mission is to develop a broadly accessible treatment for multiple indications of high unmet need. Using a novel approach by calming the natural immune response to a multi organ disease, CytoAgemts' lead drug candidate, GP1681, is positioned to become a new best practice in medicine.
Experience ยท 10 entries
All (10)
Investments (5)
Founder (1)
Board (2)
2020
Board Member
Sep 2020
Circadiance develops, manufactures and markets respiratory products for people with sleep-disordered breathing, who need non-invasive ventilation or who require monitoring. Circadiance is a pioneer in respiratory therapy specializing in positive airway pressure, non-invasive ventilation and apnea monitoring. Our clinically proven, innovative solutions address patients ranging from premature newborns to frail elderly. Circadiance products deliver superior patient comfort and effectiveness in the acute care and home care settings, ultimately resulting in reduced cost of care and improved outcomes.
Board Member
Jul 2020
The Angel Capital Association (ACA) is the professional society of angel groups and private investors that invest in high growth, early-stage ventures. Our mission is to fuel the success of angel groups and private investors that invest in high growth, early-stage ventures. ACA provides professional development and delivers services and benefits to support the success of ACA members. We also serve as the promotional voice for the global angel community and the public policy voice for the US professional angel community. ACA membership includes more than 250 angel groups, accredited platforms and family offices from across the world. Our members represent more than 8,000 accredited investors funding approximately 5,000 portfolio companies.
Private Investor
Mar 2020
A talent marketplace that uses innovative technology, career development, and a focus on skills-based hiring to create employment solutions for companies and remote careers for military and veteran spouses. Visit us at instantteams.com to learn more.
2019
Private Investor
Oct 2019
Joylux is a leading menopausal platform company offering high-tech, home-use medical and wellness devices, digital tools, and products that address menopause-related intimate health concerns. Anchored by our innovative vFit Gold device โ€“ the first home-use device using the power of red light to improve vaginal wellness โ€“ and supported by the Joylux Gold app, our products are Ob-Gyn designed with one goal in mind: empowering women to feel healthy and confident in every stage of their lives.
Private Investor
Jun 2019
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. There are many causes of CRS and our mission is to develop a broadly accessible treatment for multiple indications of high unmet need. Using a novel approach by calming the natural immune response to a multi organ disease, CytoAgemts' lead drug candidate, GP1681, is positioned to become a new best practice in medicine.
Show all 10 entries โ†“
Investment activity
2019โ€“2020 ยท 5 investments
2019220203
Recent (last 2 years)Earlier